What is the purpose of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy?
The purpose of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy was to evaluate the efficacy of optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden. This study was published in the Circulation journal in 2008 and demonstrated that medical therapy alone is sufficient to reduce ischemic burden in patients with coronary artery disease.